Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C37H40N2O6 |
Molecular Weight | 608.7233 |
Optical Activity | ( + ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CC=C(OC4=CC(C[C@@]5([H])N(C)CCC6=C5C(OC7=C(OC)C=C(CCN1C)C2=C7)=C(OC)C(OC)=C6)=CC=C4O)C=C3
InChI
InChIKey=DFOCUWZXJBAUSQ-URLMMPGGSA-N
InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(41-3)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-31-18-23(8-11-30(31)40)17-29-35-25(13-15-39(29)2)20-34(42-4)36(43-5)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. | 2002 Jul |
|
Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. | 2002 May |
|
Inhibition of Na(+),K(+)-ATPase by the extract of Stephania cephararantha HAYATA and bisbenzylisoquinoline alkaloid cycleanine, a major constituent. | 2003 Aug 1 |
|
[Determination of four alkaloids in Berberis plants by HPLC]. | 2003 Dec |
|
[Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism]. | 2003 Dec |
|
Integrity of actin-network is involved in uridine 5'-triphosphate evoked store-operated Ca2+ entry in bovine adrenocortical fasciculata cells. | 2003 Jan |
|
Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. | 2003 Nov |
|
[Distribution of four alkaloids in plants of Berberis]. | 2004 Feb |
|
Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). | 2006 Sep |
|
Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. | 2007 May 5 |
|
Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. | 2008 Jul 15 |
|
Studies on alkaloids binding to GC-rich human survivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry. | 2008 Mar |
|
Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. | 2009 Apr |
|
Berbamine derivatives: a novel class of compounds for anti-leukemia activity. | 2009 Aug |
|
The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. | 2009 Jul |
|
A new dawn for the use of traditional Chinese medicine in cancer therapy. | 2009 Mar 20 |
|
Suppression of human lung cancer cell growth and migration by berbamine. | 2010 Aug |
|
A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. | 2010 Jul |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
848121
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
275182
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
C162341
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
V5KM4XJ0WM
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
121842
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
100000124515
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
207-523-5
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
DTXSID40963943
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
478-61-5
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
BERBAMINE
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
m2425
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB32535
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)